Home
Conditions
Anemia, Refractory

Clinical trial condition

Anemia, Refractory

Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.

188 public trials 35 recruiting studies

Refine in advanced search Browse all conditions

Anemia, Refractory trial results

Completed

VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome

NCT00049686

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +29 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

3-AP and Cytarabine in Treating Patients With Hematologic Cancer

NCT00064090

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +33 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies

NCT00070538

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +29 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

NCT00004255

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +25 more
Locations: University of California San Diego Cancer Center La Jolla, California, United States

Presbyterian-St Luke's Medical Center Denver, Colorado, United States

Lombardi Cancer Center Washington D.C., District of Columbia, United States

Shands Hospital and Clinics, University of Florida Gainesville, Florida, United States

View all 15 locations

View Trial Details

Completed

Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00002800

Conditions: Agranulocytosis, Anemia, Anemia, Refractory, +26 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia

NCT00002890

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

PS-341 in Treating Patients With Hematologic Cancer

NCT00006098

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +46 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies

NCT00038051

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +19 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia

NCT00278330

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +32 more
Locations: Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer

NCT00627666

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +38 more
Locations: Asan Medical Center - University of Ulsan College of Medicine Seoul, South Korea

View Trial Details

Anemia, Refractory

Anemia, Refractory trial results

Related conditions